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The mitochondrial phosphate carrier (PiC),4 encoded by the
nuclear gene SLC25A3, catalyzes the transport of inorganic
phosphate (Pi) into the mitochondrial matrix (for a review, see
Ref. 1); transport is electroneutral and either in symport with
H⫹ or in exchange for OH⫺. PiC is a typical member of the
family of mitochondrial inner membrane carriers with six
transmembrane segments, 3-fold symmetry, and N and C termini projecting into the intermembrane space (2). SLC25A3
has alternatively spliced forms of exon 3 (referred to as exon 3A
and 3B) giving rise to PiC-A and PiC-B isoforms. PiC-B is
expressed ubiquitously, whereas PiC-A is confined to cardiac
and skeletal muscle (3, 4). PiC-A has a 3-fold higher transport
affinity for Pi, whereas PiC-B has a 3-fold higher maximal transport rate (5). Turnover rate has been estimated at 50,000/s at
25 °C, which is high among carriers (6).
The transport characteristics of PiC favor it as the most
important, or only, means of supplying Pi for oxidative phosphorylation (oxphos) as well as for other Pi-dependent processes within the matrix such as Ca2⫹ buffering. The functional
importance of the PiC was first demonstrated in yeast (Saccharomyces cerevisiae) that exhibited delayed growth or failed to
grow on non-fermentable substrate when deleted for MIR1, the
yeast homologue of PiC (7). That the yeast ⌬MIR1 mutant fails
to thrive specifically when grown on mitochondrial substrates
supports the relevance of MIR1 for oxphos.
Fundamental aspects of Pi transport into mammalian mitochondria and its role in oxphos have been known for decades.
However, only very recently has the role of PiC in oxphos and
other aspects of mitochondrial function such as in control of
the permeability transition pore been directly tested in mammals. This was achieved using mouse models of conditional
heart-specific PiC depletion (8, 9) and depletion of PiC in HeLa
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4

The abbreviations used are: PiC, mitochondrial phosphate carrier; oxphos,
oxidative phosphorylation; PiC-A, PiC isoform A; PiC-B, PiC isoform B; Ctrl,
control; JO2, O2 consumption; PA-GFP, photoactivatable green fluorescent
protein; RPA, region of photoactivation; MFN1, mitofusin 1; MFN2, mitofusin 2; kd, knockdown; FCCP, carbonyl cyanide p-trifluoromethoxyphenylhydrazone; mtDsRed, mitochondrial matrix-targeted DsRed1; mtPAGFP, mitochondrial matrix-targeted photoactivatable GFP; PiC mutant,
individual expressing the compound heterozygous PiC mutation; MAS,
mitochondrial assay solution; Hum, humanized; ANOVA, analysis of
variance.

VOLUME 291 • NUMBER 50 • DECEMBER 9, 2016

Downloaded from http://www.jbc.org/ at Thomas Jefferson University on January 5, 2017

The relevance of mitochondrial phosphate carrier (PiC),
encoded by SLC25A3, in bioenergetics is well accepted. However, little is known about the mechanisms mediating the cellular impairments induced by pathological SLC25A3 variants. To
this end, we investigated the pathogenicity of a novel compound
heterozygous mutation in SLC25A3. First, each variant was
modeled in yeast, revealing that substituting GSSAS for QIP
within the fifth matrix loop is incompatible with survival on
non-fermentable substrate, whereas the L200W variant is functionally neutral. Next, using skin fibroblasts from an individual
expressing these variants and HeLa cells with varying degrees of
PiC depletion, PiC loss of ⬃60% was still compatible with
uncompromised maximal oxidative phosphorylation (oxphos),
whereas lower maximal oxphos was evident at ⬃85% PiC depletion. Furthermore, intact mutant fibroblasts displayed suppressed mitochondrial bioenergetics consistent with a lower
substrate availability rather than phosphate limitation. This was
accompanied by slowed proliferation in glucose-replete
medium; however, proliferation ceased when only mitochondrial substrate was provided. Both mutant fibroblasts and
HeLa cells with 60% PiC loss showed a less interconnected
mitochondrial network and a mitochondrial fusion defect
that is not explained by altered abundance of OPA1 or
MFN1/2 or relative amount of different OPA1 forms. Altogether these results indicate that PiC depletion may need to
be profound (>85%) to substantially affect maximal oxphos
and that pathogenesis associated with PiC depletion or loss of
function may be independent of phosphate limitation when
ATP requirements are not high.

PiC in Mitochondrial Metabolism, Dynamics, and Cell Survival

cells (10) and through the discovery of pathologic variants in
the human gene (11–13). These variants are both in exon 3A,
specifically c.158 –9A3 G and c.215G3 A, which each cause a
frameshift and absence of protein. Functional analyses in skeletal muscle biopsy from homozygous individuals revealed
greatly suppressed pyruvate and succinate oxidation rates
despite elevated rates of maximal electron transport chain
activity (11). Phenotypically, the individuals harboring these
exon 3A mutations displayed muscle-related abnormalities
soon after birth, namely elevated blood lactate, hypertrophic
cardiomyopathy, and skeletal muscle hypotonia.
The first variants in SLC25A3 that potentially impact both
PiC-A and PiC-B were recently described by one of us in a case
report (13). An infant was diagnosed prenatally with cardiac
hypertrophy, subsequently required a heart transplant, and is
stable. There was no evidence of lactic acidosis or of skeletal
muscle dysfunction. Whole-exome sequencing revealed a
compound heterozygous mutation in SLC25A3: c.599T3 G
(p.L200W) and 22c.886_898delGGTAGCAGTGCTTinsCAGATAC23 (p.Gly296_Ser300delinsGlnIlePro). These represent two novel variants in SLC25A3 and impact both PiC
isoforms. Protein modeling predicted both variants to be pathogenic (13).
Although the relevance of PiC in bioenergetics and in human
health is now understood, little is known about its role at the
cellular level and the specific mechanisms mediating the cellular impairments induced by pathological PiC variants (11, 12).
For example, PiC depletion likely affects mitochondrial ATP
production that is central to mitochondrial fusion and mitochondrial quality control. In the current report, we use yeast
and mammalian cell models, including primary fibroblasts harboring the compound heterozygous mutation, to elucidate the
pathogenicity of the novel variants, both individually and when
co-expressed as heterozygous variants. In addition, we study
DECEMBER 9, 2016 • VOLUME 291 • NUMBER 50

the impact of PiC depletion on energy metabolism and mitochondrial dynamics.

Results
The PICQIP Mutant, but Not PICL200W, Is Non-functional—
The identified human PiC mutations were each transformed
into the ⌬mir1 yeast strain (Fig. 1A). Additionally, a humanized
version of yeast Pic1p (PICHum) was included to delineate consequences of the mutation from that of the inherent differences
between human and yeast proteins. The PICL200W missense
variant, which models the point mutation, was similar to wildtype (WT) human PiC in terms of protein amount and functional growth (Fig. 1, A and B). Furthermore, there was no
expression or growth defect observed for PICL200W even at elevated temperature (37 °C) (Fig. 1, C and D). In contrast, the
PICQIP variant, which models the GSSAS 3 QIP mutation,
resulted in a slightly decreased protein level (see Fig. 1A, compare QIP with Hum) and the inability to survive in respiratory
medium (Fig. 1B), consistent with a defect in oxphos. These
effects cannot be attributable to the humanized construct
because reconstitution with PICHum, which expresses the wildtype GSSAS sequence, showed comparable expression and
functionality to WT yeast at both optimal and higher temperatures (Fig. 1, A–E).
Because these novel PiC mutations were identified in a compound heterozygote, we used the yeast model to ask whether
PICQIP could act in a dominant negative manner. To this
end, pRS316PICQIP was transformed into ⌬mir1(pRS315),
⌬mir1(pRS315PIC1), ⌬mir1(pRS315PICL200W), or ⌬mir1
(pRS315PICHum) strains. Growth on fermentable substrate was
normal for all strains (Fig. 1D) and was hindered on non-fermentable substrate only when two copies of PICQIP were
expressed. Thus, PICQIP is not sufficient to cause problems in
expression and respiratory growth in yeast when a functional
JOURNAL OF BIOLOGICAL CHEMISTRY

26127

Downloaded from http://www.jbc.org/ at Thomas Jefferson University on January 5, 2017

FIGURE 1. Modeling the novel compound heterozygous mutation in human PiC using yeast. A, steady-state protein expression and growth analyses of PiC
variants and humanized PiC in comparison with WT. Immunoblotting for Pic1p and the loading controls Tom70p and Atp2p was done using yeast whole cell
extracts. B, 1:4 dilutions of the same set of strains were tested for functional growth using the indicated media. Plates were incubated at 30 or 37 °C for 3 days
except for YPEG at 37 °C, which was cultured for 10 days. C, steady-state protein expression and growth analyses of WT PIC, PICL200W variant, and PICHum in the
presence or absence of co-expressed PICQIP as in A. D, 1:4 dilutions of the same set of strains were tested for functional growth using the indicated media at the
designated temperature. Plates were incubated for 3 days (YPD at 30 °C), 5 days (YPD at 37 °C and YPEG at 30 °C), or 13 days (YPEG at 37 °C). E, quantification
of PIC or PICL200W protein amounts at 37 °C in the presence or absence of PICQIP (n ⫽ 9). Data are presented as means; error bars represent S.E. n.s., differences
not significant. EV, empty vector; YPD, 1% yeast extract, 2% peptone, 2% dextrose; YPEG, 1% yeast extract, 2% peptone, 1% ethanol, 3% glycerol.
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copy of PIC (WT, L200W, or humanized) is present (Fig. 1, C
and D).
Delayed Proliferation and a Lower Functional Respiratory
Capacity in PiC Compound Mutant Fibroblasts—We obtained
primary skin fibroblasts from the individual expressing the
compound heterozygous PiC mutation (PiC mutant) (13) as
well as from four control (Ctrl) individuals. The tendency for a
lower expression of PiC protein in the yeast cells transformed
with the QIP mutation prompted us to evaluate PiC mRNA and
protein expression in the fibroblasts. For quantitative PCR,
primers recognizing mRNA for the PiC-A and PiC-B isoforms
were validated using human skeletal myoblasts, which are
known to predominantly express PiC-B and then to up-regulate
PiC-A upon differentiation into myotubes (Fig. 2A). Quantitative PCR analysis using these validated primers revealed
unchanged mRNA levels for both isoforms in PiC mutant fibroblasts (Fig. 2A; note that PiC-B is the predominant isoform in
fibroblasts). Differently, immunoblot analysis using an antibody raised against the full-length PiC protein showed that PiC
expression was ⬃40% of the level in Ctrl fibroblasts as determined using fibroblasts from four healthy individuals (Fig. 2B;
the representative blot shows two of the control fibroblast
lines); the antibody typically revealed two bands, and only the
upper band was quantified. Lower molecular weight fragments,
which would indicate cleavage products, were not detected. In
contrast to this lower PiC protein abundance, the protein
expression level of many other mitochondrial proteins was similar between PiC mutant and Ctrl cells (Fig. 2B), pointing to a
selective decrease in PiC protein in PiC mutant cells.
To investigate the effect of the PiC compound heterozygous
mutation on proliferative capacity in a mammalian system, the
primary skin fibroblasts were grown in parallel with Ctrl skin
fibroblasts in different media. PiC mutant cells grown in glu-
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cose-rich medium appeared healthy but divided more slowly
with a doubling time that was approximately twice the Ctrl rate
(Fig. 3, upper and middle panels) whether cells were grown in 5
mM glucose or in 25 mM glucose. When cells were challenged
with medium free of glucose and containing only mitochondrial substrates (␤-hydroxybutyrate and glutamine), Ctrl fibroblasts continued to proliferate although at a much slower rate.
In contrast, PiC mutant fibroblasts could not maintain proliferation when glucose was unavailable (Fig. 3, lower panel).
Although the yeast models indicated the lack of a dominant
negative effect of the GSSAS 3 QIP mutation, the patientderived fibroblasts suggested that the presence of the mutation
rendered the PiC protein unstable, leading to substantially
lower levels of PiC protein, which could suppress oxphos. To
determine whether this occurred, O2 consumption (JO2) was
measured. Intact PiC mutant fibroblasts grown and studied in
low or high glucose (plus 4 mM glutamine) had ⬃50% of the
basal mitochondrial JO2 (i.e. minus the rate measured after
addition of antimycin to inhibit complex III of the electron
transport chain) of the Ctrl cells (Fig. 4A shows raw O2 traces
from an experiment, and Fig. 4B shows group averages). To
indirectly determine whether a Pi limitation on oxphos could
account for the lower basal JO2, we evaluated the leak-dependent mitochondrial JO2 (i.e. after addition of oligomycin to
inhibit the ATP synthase) and the uncoupler-driven JO2 (using
FCCP to evaluate electron transport chain capacity under the
prevailing substrate conditions); if a Pi limitation on oxphos was
the sole driver of the lower basal JO2 in PiC mutant cells, then
leak-dependent and uncoupled JO2 should remain similar to
that in Ctrl cells. Differently, both of these were lower in PiC
mutant cells, pointing to a broader defect that results in not
only lower basal JO2 but also decreased functional capacity of
the electron transport chain.
VOLUME 291 • NUMBER 50 • DECEMBER 9, 2016
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FIGURE 2. Lower PiC protein expression in primary fibroblasts harboring the compound heterozygous PiC mutation. A, mRNA, as assessed by quantitative PCR analysis, of isoforms A and B was unchanged by the PiC mutant. Ctrl data were obtained from fibroblasts from three normal individuals; PiC mutant
data were obtained from two different passages of the fibroblasts expressing the compound SLC25A3 mutation. As controls for identification of isoform A and
B mRNA, mRNA was isolated from primary human skeletal myoblasts and myotubes (upper panels); myotubes were expected to show up-regulated PiC-A
compared with myoblasts. B, left panels, example of an immunoblot from PiC mutant fibroblasts and Ctrl fibroblasts from two different individuals. Arrow, band
used to quantify PiC abundance. Right panel, quantification from Ctrl fibroblasts from four normal individuals (each tested at three different passages) and from
five separate passages (less than passage 10) of the PiC mutant fibroblasts. For each genotype, band intensity was first normalized to that of ␣-tubulin. Data are
presented as means, and error bars represent S.E. except for the skeletal muscle cells, which are each from a single sample. C-I, C-II, and C-III, complexes I, II, and
III; Cyto-c and cyt c, cytochrome c.

PiC in Mitochondrial Metabolism, Dynamics, and Cell Survival

To further investigate the possibility of a Pi limitation on
oxphos in PiC mutant fibroblasts, JO2 was measured in permeabilized cells supplied with either pyruvate ⫹ malate (Fig. 4B) or
succinate ⫹ rotenone (not shown) and in the presence of saturating ADP (maximal phosphorylating JO2; state 3), followed by
addition of oligomycin and then of FCCP. There were no differences between Ctrl and PiC mutant cells for either of the
substrates or any of the conditions. Notably, state 3 JO2 was not
different, indicating the availability of sufficient Pi to drive maximal oxidative phosphorylation in PiC mutant cells.
HeLa Cells with Substantial PiC Depletion Can Sustain Oxidative Phosphorylation—The continued presence in PiC
mutant fibroblasts of oxphos, despite the ⬃60% lower PiC protein abundance, suggested either that the capacity of PiC is far
in excess of its requirement for oxphos in these cells or that
DECEMBER 9, 2016 • VOLUME 291 • NUMBER 50

alternative sources of Pi are available to the matrix. To further
test whether lower PiC can be compatible with substantial
oxphos, PiC was acutely depleted in HeLa cells using siRNA;
two different siRNA duplexes were investigated (kd1 and kd2;
Fig. 5). By 72 h post-siRNA introduction, PiC protein was ⬃15%
of control levels (Fig. 5A). In contrast, the protein expression
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. Slower proliferation rate in primary skin fibroblasts harboring
the compound heterozygous PiC mutation. Cells tested in glucose plus
glutamine had been growing in that substrate condition for two to three
passages. Cells tested in ␤-hydroxybutyrate (BHB) plus glutamine (no glucose) were switched to that condition the day before cell counting was
started. DMEM ⫹ 10% FBS was used as the base medium throughout. n ⫽ 3– 6
growth curves/genotype derived from cells at different passages (less than
passage 10). In the 25 mM glucose and no glucose conditions, Ctrl cells were
from two different subjects (n ⫽ 3/subject). In the 5 mM glucose condition,
Ctrl cells were from one subject. Data are presented as means; error bars represent S.E. Doubling time was significantly longer in PiC mutant cells; p values
were calculated using an unpaired t test. fibro, fibroblasts.

FIGURE 4. Suppressed bioenergetics in intact but not permeabilized PiC
mutant skin fibroblasts. A, raw O2 traces from a single experiment where a
Ctrl line and the PiC mutant cells were studied in parallel. Cells were grown
and the experiment was performed in 5 mM glucose ⫹ 4 mM glutamine as
substrates. Values are means ⫾ S.D. with six technical replicates each. Oligomycin (Oligo) was injected to inhibit ATP synthase to measure leak-dependent respiration. Capacity of the electron transport chain under the prevailing
substrate condition was determined using the chemical uncoupler FCCP.
Finally, antimycin was injected to inhibit the electron transport chain to
reveal non-mitochondrial O2 consumption. Note that protein abundance was
similar for Ctrl and PiC mutant cells (⬃10% higher for mutant cells). B and C, all
values are mitochondrial O2 consumption rates calculated by subtracting the
O2 consumption rate measured after antimycin. The basal rate is the rate
measured in the absence of inhibitors or uncoupler. Cells were grown in the
indicated substrate conditions for two to three passages before testing in
those conditions. p values are as follows: ***, p ⬍ 0.01 from Tukey post
hoc test after two-way ANOVA (p ⫽ 0.011 for genotype ⫻ JO2 condition interaction); **, p ⫽ 0.03 from two-way ANOVA (genotype ⫻ JO2 condition interaction not significant; p ⫽ 0.03 for genotype main effect; p ⬍ 0.001 for JO2
condition main effect). C, cells were cultured in the indicated media and then
preincubated in those media for 45 min in 0 CO2 before being switched to
intracellular medium containing 10 mM pyruvate, 2.5 mM malate, saturating
ADP, and a permeabilizing reagent (see “Experimental Procedures” for further
details). Permeabilization was confirmed by showing robust succinate-driven
O2 consumption; succinate does not cross the plasma membrane (not
shown). Data were normalized to total cellular protein from parallel plates of
intact cells. n ⫽ 3/genotype from cells at different passages (less than passage
10). In B and C, data are presented as means, and error bars represent S.E. For
the 5 mM glucose condition, n ⫽ 4/genotype from cells at different passages
(less than passage 10). For the 25 mM glucose condition, four separate Ctrl
fibroblast lines were tested, each in triplicate (three different passages); triplicates were averaged. Data from PiC mutant cells were split into parallel cultures for the different controls and then tested at three different passages
each. Thus, n ⫽ 4/genotype for 25 mM glucose.
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level of other mitochondrial proteins was unchanged 72 h
post-siRNA treatment (Fig. 5A). Cell proliferation, measured
using cells seeded at 48 h post-siRNA addition, was delayed by
PiC depletion (Fig. 5B). Measurements of JO2 in permeabilized
cells revealed a 30 – 40% suppression of state 3 JO2 with either
pyruvate ⫹ malate (Fig. 5C) or succinate (⫹rotenone; not
shown), whereas leak-dependent JO2 and uncoupled JO2 were
unchanged by PiC knockdown (Fig. 5C); these results are consistent with a Pi limitation on oxphos as the cause of the lower
state 3 JO2. In intact cells, substantial PiC depletion had no
effect on basal, leak-dependent, or uncoupler-driven JO2. We
further investigated oxphos in HeLa cells that had a lesser acute
depletion of PiC; cells were depleted by ⬃60 – 65% (Fig. 5D),
which is similar to the extent of the PiC decrease in PiC mutant
fibroblasts (Fig. 2B). In contrast to permeabilized HeLa cells
with ⬃85% decrease in PiC, permeabilized HeLa cells expressing slightly more PiC had the same maximal phosphorylating
JO2 as Ctrl HeLa cells. Altogether, the data from intact and
permeabilized HeLa cells with different levels of PiC deletion

26130 JOURNAL OF BIOLOGICAL CHEMISTRY

further support that at least some oxphos can be maintained
despite substantial PiC depletion.
Altered Mitochondrial Morphology in PiC Compound
Mutant Fibroblasts and in HeLa Cells with Acute PiC
Depletion—Emerging literature supports a mutual relationship
between mitochondrial function and form (15). Indeed, visualization of mitochondrial morphology in fibroblasts expressing
mitochondrial matrix-targeted DsRed1 (mtDsRed) revealed
fewer elongated mitochondria in PiC mutant than in Ctrl fibroblasts (Fig. 6, A and B). Furthermore, in HeLa cells with ⬃60%
decrease in PiC a similar change in the mitochondrial form was
obtained (Fig. 6C). A decrease in the fraction of elongated
organelles can result from decreased mitochondrial fusion or
increased mitochondrial fission.
Less Fusion Activity in PiC Compound Mutant Fibroblasts
and in HeLa Cells with Acute PiC Depletion—To evaluate
directly whether the distinct mitochondrial morphology in PiC
patient and control fibroblasts can result from different levels of
interorganellar continuity and fusion events, the cells were coVOLUME 291 • NUMBER 50 • DECEMBER 9, 2016
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FIGURE 5. Acute PiC depletion in HeLa cells is still associated with substantial phosphorylating O2 consumption. A, immunoblots from HeLa cells
exposed for 72 h to one of two different siRNA duplexes targeting PiC or scrambled controls. For each genotype, bands were normalized to either succinate
dehydrogenase subunit A (SDHA) or ␣-tubulin. n ⫽ 3/genotype. B, growth curves in HeLa cells exposed to siRNA for 72 h and grown in DMEM ⫹ 25 mM glucose ⫹
4 mM glutamine. p values (doubling times) are from an unpaired t test. n ⫽ 3/genotype. C, mitochondrial bioenergetics measured in cells exposed to one of two
different siRNA duplexes for 72 h, grown and tested in either DMEM ⫹ 25 mM glucose ⫹ 4 mM glutamine (Intact), or permeabilized and supplied with pyruvate
and malate (Permeabilized). See “Experimental Procedures” and Fig. 4 for further details. n ⫽ 3–5/genotype. D, immunoblots showing lesser depletion of PiC in
HeLa cells exposed to siRNA for 48 h. Cells were grown in DMEM ⫹ 25 mM glucose ⫹ 4 mM glutamine, and mitochondrial bioenergetics were measured in that
medium (Intact) or subsequently permeabilized and supplied with pyruvate and malate (Permeabilized). See Fig. 4 for further details. n ⫽ 3–5/genotype. In all
panels, data are presented as means, and error bars represent S.E. For the immunoblots, p values are as follows: ***, p ⬍ 0.01; **, p ⫽ 0.02; *, p ⬍ 0.046 (unpaired
t test). For the JO2 measurements, p values are as follows: ***, p ⬍ 0.001; *, p ⫽ 0.035 (Tukey post hoc tests following two-way ANOVA with significant
genotype ⫻ JO2 condition interaction). Two different siRNA duplexes were used (kd1 and kd2), and controls were run with each (Ctrl 1 and Ctrl 2). Oligo,
oligomycin; C-I, C-II, and C-III, complexes I, II, and III; cyto-c, cytochrome c.
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FIGURE 6. Mitochondrial morphology in primary PiC mutant fibroblasts and PiC-deficient HeLa cells. Mitochondrial morphology was scored as follows:
fragmented, mainly small and round; partly fragmented, intermediate, mixture of round and shorter tubulated; normal, tubulated, long and higher interconnectivity; elongated, very long, tubulated. The percentage of cells with the indicated mitochondrial morphologies was determined as a percentage of the total
number of DsRed-transfected cells counted (ⱖ18 cells per experiment; n ⫽ 4 independent experiments). A, representative figures of the different mitochondrial forms in Ctrl and PiC mutant fibroblasts. B, distribution of the different type of mitochondria in primary fibroblasts. C, distribution of the different types of
mitochondria after PiC silencing in HeLa cells. Scr., scrambled siRNA; PiC kd1 and kd2, two different PiC-specific duplexes.

DECEMBER 9, 2016 • VOLUME 291 • NUMBER 50

OPA1 was unaltered in PiC mutant fibroblasts (Fig. 8A). A shift
in OPA1 immunoreactivity from the high to the lower molecular weight bands indicates a decrease in the fusion-competent
forms (as induced by FCCP; Fig. 8B). However, no change in the
relative abundance of the high and low molecular weight bands
appeared in the PiC mutant fibroblasts (Fig. 8B). Among the
main outer membrane fusion proteins, mitofusin 1 (MFN1)
was slightly but significantly decreased, whereas mitofusin 2
(MFN2) and the main fission protein DRP1 were unchanged
(Fig. 8A). In HeLa cells with 60% PiC depletion, the abundance
of none of these fusion and fission proteins was altered (Fig.
8C). Collectively, the results in two different paradigms of PiC
depletion show suppressed mitochondrial fusion activity. However, the decreased fusion activity cannot be attributed to processing of OPA1 to fusion-incompetent forms or to substantial
loss of another fusion protein.

Discussion
The novel compound heterozygous mutations in SLC25A3
described here and previously (13) were associated in vivo with
respiratory distress and hypertrophic cardiomyopathy but with
unremarkable function of other organs, including skeletal muscle (13). The pathological potential of the novel SLC25A3 mutations was not tested directly and was our aim. Here we report
that the point mutation is likely to be functionally neutral,
whereas the GSSAS 3 QIP variant has relevance compatible
with a loss of function. Furthermore, the GSSAS 3 QIP variant
does not obligatorily act as a dominant negative. However, in
primary fibroblasts harboring the compound heterozygous PiC
mutation and thus one potentially functional allele, PiC protein
abundance was substantially lower, and the cells were not phenotypically normal; the most dramatic phenotype was a proliferation time that was approximately half the control rate and an
inability to divide when supplied with only mitochondrial substrates. PiC mRNA was unaffected by the mutations. Thus the
compound heterozygous PiC mutation has a functional impact
in mammalian cells with instability of the PiC protein as a likely
initiating factor. We also found in patient fibroblasts, as well as
HeLa cells with different levels of acute PiC loss, that PiC protein
could be substantially depleted before oxidative phosphorylation
was suppressed. This suggests that the PiC can be expressed in
excess of oxphos needs or that other PiC transport mechanisms
can compensate. However, PiC mutant fibroblasts could not proliferate in mitochondrial substrate, suggesting that a partial depleJOURNAL OF BIOLOGICAL CHEMISTRY
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transfected with cDNA encoding mtDsRed and mitochondrial
matrix-targeted photoactivatable GFP (mtPA-GFP). Using
confocal microscopy, a time series of fluorescence images was
recorded, and 25-m2 square-shaped areas were illuminated by
a pulsed laser to photoactivate mtPA-GFP (16, 17). Mitochondrial matrix continuity and connectivity are unveiled by the
diffusion of the photoactivated PA-GFP to the regions outside
the 2 photon illuminated area. Image time series indicated less
mtPA-GFP diffusion in PiC mutant than in Ctrl fibroblasts (Fig.
7A). To quantify connectivity, the time course of the ratio of
FmtPA-GFP and FmtDsRed was calculated for the region of photoactivation (RPA) (Fig. 7A). The slower decay of the fluorescence
ratio in the RPA indicates a decrease in the combined activity of
mitochondrial network formation (40 s) and mitochondrial
fusion and mitochondrial movements (500 s) in the PiC mutant
fibroblasts (Fig. 7B). To validate fusion events, reciprocal
spreading of mtPA-GFP and mtDsRed among mitochondria
that were not continuous at the time of mtPA-GFP photoactivation was sought. The fusion events were quantitatively analyzed by the progression of the distribution of mtPA-GFP fluorescence between the images collected within the first 24 s and
8 min after photoactivation. The result of manual counting
indicates less mitochondrial fusion activity in the PiC mutant
fibroblasts. The total fusion numbers were decreased significantly in the mutant fibroblasts (Fig. 7C). Although Fig. 7C
shows fusion event number for only one control fibroblast line
that was studied side by side with the PiC mutant, the fusion
event numbers were very similar in other control fibroblast
lines (7.3 ⫾ 0.3 versus 6.5 ⫾ 0.1, 7.5 ⫾ 0.1, and 6.4 ⫾ 0.3; n ⫽
3–7). Conversely, the average duration of individual fusion
events was similar in both PiC mutant fibroblasts and Ctrl (Fig.
7D). Furthermore, the distribution of different fusion types in
terms of rapid reversal and orientations (Fig. 7E) did not show
any alterations in PiC mutant fibroblasts as compared with the
Ctrl. In HeLa cells with ⬃60% decrease in PiC (attained by two
different siRNA duplexes, kd1 and kd2), the mitochondrial
connectivity and fusion activity were similarly decreased as in
the mutant fibroblasts (Fig. 7, F–I).
ATP produced by oxphos is required to maintain the fusion
promoting activity of OPA1, the inner mitochondrial membrane fusion protein (18, 19). To test whether the decreased
mitochondrial fusion activity can be attributed to a change in
OPA1 or another mitochondrial fusion protein, immunoblotting was performed in whole cell lysates. The total abundance of
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FIGURE 7. Mitochondrial continuity and fusion activity in primary fibroblasts. A, image time series showing a representative fibroblast before and after 2P
photoactivation of mtPA-GFP (white squares) at 0 s (first step of the imaging), 24 s (first step directly after photoactivation), 40 s (the mtPA-GFP diffusion within the first
16 s of photoactivation), and 500 s (further spreading after 8 min). A region of interest for each condition (dashed white line) is magnified and shown as PA-GFP only
(green) images for each time point. B, the time course of the ratio of FmtPA-GFP and FmtDsRed for the RPA (above) and the decay of the fluorescence ratio in the RPA at 40
and 500 s (below). Asterisks indicate significant differences (p ⬍ 0.05). C, fusion event rate in primary fibroblasts. D, average fusion times. E, distribution of different fusion
types (left) and orientation (right). F–I, HeLa cells treated with scrambled siRNA or kd1 or kd2 duplexes targeting PiC. F, the time course of the normalized FmtPA-GFP for
the region of photoactivation (RPA) (left) and the decay of the fluorescence ratio in the RPA at 500 s (right). Asterisks indicate significant differences (p ⬍ 0.05). Scr.,
scrambled siRNA-silenced cells; PiC kd1 and kd2, PiC siRNA-treated cells. G, fusion event rate in silenced HeLa cells. H, average fusion times in silenced HeLa cells. I,
distribution of different fusion types (left) and orientation (right) in silenced HeLa cells. In B, C, D, F, G, and H, error bars represent S.E.

tion of PiC can become pathogenic when demand for mitochondrial ATP is high. Finally, PiC mutant fibroblasts, as well as HeLa
cells with acute PiC loss, had a more fragmented mitochondrial
network and slower rate of inner mitochondrial membrane fusion,
raising the possibility that organ pathology might be contributed
by dysfunctional mitochondrial processes other than, or in addition to, suppressed oxphos.
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The ⌬mir1 yeast strain transformed with one or both of the
newly identified human PiC variants was used to evaluate the
functional relevance of these variants. Leu-200 is conserved
among mammalian species and in yeast and is located within a
region that is fully to strongly conserved between human and
yeast. Based on the model of PiC determined by Bhoj et al. (13),
Leu-200 resides in a small matrix helix that connects transVOLUME 291 • NUMBER 50 • DECEMBER 9, 2016
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membrane helices 3 and 4 and interacts with adjacent hydrophobic residues near PX(D/E)XX(K/R), the consensus
sequence of all inner mitochondrial membrane carrier proteins. It was predicted that substitution of leucine for tryptophan would not be well tolerated due to tryptophan’s large
hydrophobic side chain, which would be exposed to the solvent
and could introduce steric clashes (13). However, the L200W
substitution did not prevent growth on mitochondrial substrate
even at elevated temperature, suggesting that this variant is
neutral. In contrast, the GSSAS 3 QIP variant prevented
growth only on mitochondrial substrate even in unchallenged
yeast and despite only slightly decreased PiC protein abundance. This is in line with a loss-of-function mutation and a
deleterious effect on oxphos. Based on the nomenclature of the
ADP/ATP carrier, GSSAS occurs at matrix loop-connecting
transmembrane helices 5 and 6. The variant replaces very small
(Gly and Ala), flexible (Gly), and polar (Ser) residues for bulky
(Gln), hydrophobic (Ile), and inflexible (Pro) residues. Thus,
GSSAS 3 QIP was predicted to not be well tolerated (13),
which is what we found here. Because previously confirmed
pathological SLC25A3 variants affected only PiC-A (11, 12),
GSSAS 3 QIP is the first variant that affects both isoforms.
PiC mutant fibroblasts with ⬃60% less PiC protein had lower
basal JO2, maximal leak-dependent JO2, and maximal electron
transport chain activity. Changes in bioenergetics caused only
by a Pi limitation on oxphos would be restricted to suppressed
phosphorylating JO2 as we observed in permeabilized HeLa
cells with ⬎85% PiC loss. In contrast, permeabilized mutant
fibroblasts had similar maximal phosphorylating JO2 as Ctrl
fibroblasts, indicating that Pi did not limit oxphos. Moreover,
lack of a difference in basal or uncoupled JO2 in permeabilized
mutant fibroblasts suggests that the abundance of assembled
DECEMBER 9, 2016 • VOLUME 291 • NUMBER 50

respiratory complexes and ATP synthase as well as their ability to
assemble into higher order complexes was unchanged in mutant
fibroblasts. Rather, the decrease in not only basal but also leak-dependent JO2 and maximal electron transport chain activity in
intact mutant fibroblasts is consistent with lower provisioning of
reducing equivalents to the electron transport chain.
The pronounced decrease in JO2 in intact mutant fibroblasts
contrasts with minimal decrease in intact HeLa cells with
greater PiC depletion. This different response to PiC depletion
may arise from long versus short term PiC loss. Another possibility is that mutant PiC protein in fibroblasts induced a stress
response that might not occur in HeLa cells that were depleted
of PiC through suppression of mRNA rather than mutation. In
fact, lower PiC protein was not predicted by either of the mutations which are in-frame; indeed, mRNA expression of both PiC
isoforms was unaffected. The lower PiC abundance in the
mutation-harboring fibroblasts is also unlikely to reflect natural
variability in translation efficiency or turnover because these
PiC variant cells deviated similarly in their PiC abundance as
compared with fibroblasts from four healthy donors. Rather,
depletion of PiC protein in the mutant fibroblasts may reflect
an inability of PiC to be properly translated or a tendency for
mutant PiC to aggregate, to be misfolded, or to be incorrectly
incorporated into complexes (which likely include dimers as
well as other components such as the adenine nucleotide translocase (20 –22)). Such disruptions in PiC protein folding might
induce a mild stress response that is partially responsible for the
mitochondrial phenotypes observed in mutant fibroblasts.
The substantial oxphos remaining in permeabilized mutant
fibroblasts and PiC-depleted HeLa cells suggests that the abundance of PiC is in excess of oxphos needs or that alternate Pi
transport pathways compensate for PiC loss. These possibilities
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 8. Abundance of mitochondrial fusion and fission proteins in PiC-deficient primary fibroblasts and HeLa cells. A, Western blotting of the main
fusion and fission proteins in the Ctrl and PiC-deficient fibroblasts. Left, representative blots; right, normalized protein abundance of the percentage of the
average protein levels of control fibroblast. B, OPA1 isoforms. FCCP (5 M) was used as a positive control to show the mitochondrial uncoupling-induced loss
of the long form of OPA1. C, Western blotting of the main fusion and fission proteins in HeLa cells. Scr., scrambled siRNA-silenced cells; PiC kd, PiC siRNA-treated
cells. Left, representative blots; right, normalized protein abundance of the percentage of the average protein levels of scrambled siRNA-silenced cells. In A and
C, error bars represent S.E.
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athy, lactic acidosis, or other obvious organ dysfunction (13). In
contrast, not only hypertrophic cardiomyopathy but also skeletal muscle hypotonia and lactic acidosis were symptoms in
individuals with homozygous mutations leading to loss of
PiC-A protein in muscle only (11, 12). PiC-B would still be
expressed; however, there did not appear to be compensation,
and the levels appeared low (12). Parenthetically, it is also not
known to what extent PiC-B can functionally compensate for
PiC-A. The compound heterozygous mutation affects both
PiC-A and PiC-B, and we have shown here that the GSSAS 3
QIP variant is deleterious and that the variant(s) can destabilize
PiC protein. However, our data also indicate that some PiC
protein remains. Furthermore, we show that some oxphos
capacity is retained even when PiC protein abundance is quite
low. The latter is also supported by mouse models of PiC depletion in the heart (8, 9). However, we also show that oxphos
capacity is sensitive to PiC abundance. We propose that these
findings are consistent with confinement of the phenotype of
the compound heterozygous mutation to cardiomyopathy
because of the incessantly high demand for ATP of the heart.
Our study has revealed that PiC depletion is accompanied by
defective cell proliferation and mitochondrial fusion and an
oxphos defect that does not depend on Pi limitation. Thus, the
pathogenesis associated with PiC depletion or loss of function
may, at least in part, reflect these deficiencies. It will also be of
interest to determine whether these deficiencies are a general
feature of pathological PiC variants.

Experimental Procedures
Molecular Biology—Yeast MIR1 gene fragment, with 470-bp
5⬘-UTR and 50-bp 3⬘-UTR, was generated by PCR using
GA74-1A genomic DNA as template and cloned into pRS315.
The PIC1 mutants, L200W and QIP (replacing amino acid residues 247–258 of yeast Pic1p) as well as a humanized version
(normal human amino acids GSSAS in place of residues 247–
258 of yeast Pic1p) were created by overlap extension (29) and
subcloned into pRS315. For the co-expression studies, PICQIP
was subcloned into pRS316. Construct verification was performed by restriction digest analysis and/or sequencing.
Yeast Strains and Growth Conditions—All yeast strains used
were derived from GA74-1A (MATa, his3–11,15, leu2, ura3,
trp1, ade8 (rho⫹, mit⫹)). The open reading frame of MIR1 was
replaced with HIS3MX6 by a PCR-based disruption method.
The resulting strain was then transformed with pRS316PIC1
to prevent loss of mtDNA, and the desired strains were generated by plasmid shuffling. In brief, pRS315, pRS315PIC1,
pRS315PICL200W, pRS315PICQIP, or pRS315PICHum was transformed into ⌬mir1(pRS316PIC1) followed by two selections in
5-fluoroorotic acid to generate clones lacking pRS316PIC1.
Growth studies were performed to evaluate yeast strain functionality. Cultures were inoculated in synthetic complete dextrose without leucine (0.17% yeast nitrogen base, 0.5% ammonium sulfate, 0.2% synthetic dropout mixture minus leucine, 2%
dextrose), grown overnight at either 30 or 37 °C, spotted in
synthetic complete medium without leucine and supplemented
with dextrose or 3% glycerol and 1% ethanol, and incubated at
the indicated temperature and duration.
VOLUME 291 • NUMBER 50 • DECEMBER 9, 2016
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are also suggested by observations made in mice with either
⬃60 or ⬎95% depletion of PiC in the heart (8, 9). Cardiac PiC
depletion of ⬃60% was associated with very mild cardiac hypertrophy and no discernible functional defect (9). Even when PiC
was depleted by ⬎95%, cardiac function was unaffected for at
least 2 weeks, and ATP in the mitochondrial fraction was 50% of
normal (8), suggesting compensation at the level of mitochondria or that very little PiC can sustain some level of oxphos.
Using a fresh skeletal muscle biopsy from an individual with a
homozygous c.215G3 A mutation affecting only PiC-A, substrate oxidation was tested using a variety of conditions and was
clearly suppressed (11). However, the extent of suppression
varied considerably, ranging from as low as ⬃10% of control
(using the lower extent of the control range) to ⬎30% of control. Because uncoupler-driven oxidation was within the control range, the variability in substrate oxidation would not be
due to differences in the capacity to supply reducing equivalents to the electron transport chain or in the capacity of the
electron transport chain itself. Rather, the variability in oxidation reported by Mayr et al. (11) could arise from variable access
to alternate Pi transport pathways such as the dicarboxylate
transporter, which exchanges succinate or malate for Pi (23).
Generally the PiC has been assumed to be the Pi uptake mechanism in mitochondria. Although the present study and those
discussed above cannot distinguish between excess PiC capacity and alternate Pi transport, the observations collectively suggest that this is an important question that needs to be
addressed by future studies.
A shift of mitochondrial morphology to a less interconnected
phenotype was present in both PiC mutant fibroblasts and
HeLa cells with quantitatively similar acute PiC depletion. This
shift can result from the observed decrease in mitochondrial
fusion activity. A sensible mechanism to underlie decreased
fusion could be a decrease in fusion-competent OPA1 that is
dependent on oxphos-derived ATP (18, 19). However, neither
total OPA1 nor the relative contribution of the different forms
was altered in mutant fibroblasts or in the PiC-depleted HeLa
cells. A decrease in the amount of the outer membrane fusion
mediator MFN1 or MFN2 could also cause suppression of
mitochondrial fusion (17, 24). Indeed, there was a lower level of
MFN1 in the mutant fibroblasts, but it was unaltered in the
PiC-deficient HeLa cells that displayed a similar mitochondrial
fusion phenotype to the fibroblasts. Furthermore, MFN2 was
unchanged in both PiC-deficient paradigms. Activity of the fusion
proteins can also be affected by posttranslational modifications,
but no specific mechanism appeared likely here and because of
that was not tested. Although the specific molecular mechanism
linking PiC activity to fusion requires further investigation, the
present findings might illuminate a common cause of mitochondrial fragmentation observed in fixed skin fibroblasts derived from
patients with various oxphos impairments with a general trend
that fragmentation increases with severity of the defect (25–28).
Based on the present results, live cell mitochondrial imaging in
single cells might detect even a mild oxphos (or mitochondrial)
defect that remains unnoticeable by JO2 measurements.
The patient harboring the compound heterozygous PiC
mutation had severe hypertrophic cardiomyopathy that
required heart transplantation but did not have skeletal myop-
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For experiments in permeabilized cells, cells were washed
and preincubated as for intact cells. After the 45-min preincubation, cells were washed again with mitochondrial assay solution (MAS) (32) (70 mM sucrose, 220 mM mannitol, 10 mM
KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA and 0.2%
(w/v) BSA, pH 7.2 at 37 °C), and then 450 l/well MAS containing 10 mM pyruvate, 2 mM malate, 4 mM ADP (from a 1 M stock
that had been adjusted to pH 7.2), and permeabilizing reagent
(1 nM after optimization; Seahorse Biosciences) were added as
the final assay medium. The final concentrations of ADP and substrates are expected to be saturating based on experiments in 5–10
g of isolated mitochondria (32, 33). Oligomycin (2.5 g/ml final)
and FCCP (4 M final) were injected sequentially. Some wells only
received a final injection of oligomycin ⫹ FCCP to record phosphorylating JO2 for a longer time to monitor the stability of JO2;
after an increase in JO2 over the first ⬃5 min of the experiment,
JO2 remained stable for at least 10 min prior to adding oligomycin
and uncoupler. The mix-wait-measure protocol used was that recommended for isolated mitochondria (32) that has worked well in
our hands (33). To verify that cells were permeabilized, in some
experiments, a subset of wells contained succinate (5 mM) and
rotenone (1 M) instead of pyruvate and malate.
For both intact cell and permeabilized cell experiments, JO2
values were normalized to total cellular protein. Plates used for
both types of experiment were always plated at the same time,
allowing us to use the protein amount obtained from the intact
cell experiment for the permeabilized cell experiment (measurement of protein from the latter was confounded by the presence
of BSA in the MAS).
Mitochondrial Fusion Dynamics—Imaging measurements
were performed as described previously (16, 17). Briefly, cells
were incubated in a 0.25% BSA-containing extracellular
medium consisting of 121 mM NaCl, 5 mM NaHCO3, 4.7 mM
KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 2 mM CaCl2, 10 mM
glucose, and 10 mM Na-Hepes, pH 7.4, at 37 °C. Recordings of
mtPA-GFP and mtDsRed (512 ⫻ 512 pixels) were performed
using 488 and 561 nm laser lines at 0.25 s⫺1 data acquisition
frequency using an LSM780 microscope and 63⫻/1.4 numerical
aperture Apoplan oil objective. Experiments were run at 37 °C. To
photoactivate PA-GFP (and photobleach Ds-Red) in 2P mode in
5 ⫻ 5-m areas, a pulsed laser system (760 nm; Chameleon,
Coherent, Inc.) was applied. Image analysis was done using either
Spectralyzer (custom designed) or Zen2010 (Carl Zeiss).
Mitochondrial dynamics was evaluated by two different
approaches. Spreading of PA-GFP from the area of photoactivation was evaluated by masking the 5 ⫻ 5-m areas and quantifying the time-dependent decay in the fluorescence ratio of
PA-GFP and DsRed. The ratio values in each region were normalized to the peak reached during 2P excitation. Fusion events
were also counted manually (34). Image analysis was performed
in Spectralyzer or Zen2010 imaging software.
Immunoblotting—For yeast studies, protein extraction from
yeast cells, SDS-PAGE, and immunoblotting were carried out
as described (35, 36). The antibodies used for the yeast studies
have been described previously (37–39). Images were captured
with the Fluorchem Q system (Cell Biosciences, Inc.), and relative protein levels were quantified using ImageJ. Statistical
analyses were performed with StatPlus. For mammalian cell
JOURNAL OF BIOLOGICAL CHEMISTRY
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To assess whether the PICQIP allele exerts a dominant negative effect on WT PIC1 or the other PIC alleles, pRS316
or pRS316PICQIP was transformed into ⌬mir1(pRS315),
⌬mir1(pRS315PIC1), ⌬mir1(pRS315PICL200W), or ⌬mir1
(pRS315PICHum). Growth analyses were done as described
above except that synthetic complete dextrose without leucine
and uracil and the same selection medium supplemented with
either dextrose or 3% glycerol and 1% ethanol were utilized for
inoculation and spotting, respectively.
Mammalian Cell Culture—Primary skin fibroblasts were
obtained from the PiC mutant (13) as well as two age-matched
controls and two controls from older individuals, resulting in
fibroblasts from four healthy individuals that were used as controls. Fibroblasts were cultured in DMEM containing 4 mM
glutamine and either 5 mM glucose or 25 mM glucose. For some
growth curve experiments, cells were cultured in glucose-free
DMEM containing 4 mM glutamine and supplemented with 5
mM ␤-hydroxybutyrate; this medium forced cells to rely on
mitochondria for ATP production (30, 31). PiC mutant and Ctrl
cells were only used for 10 passages and were always compared
at the same passage number. HeLa cells (ATCC) were cultured
in DMEM containing 25 mM glucose, 4 mM glutamine, and 1
mM pyruvate; HeLa cells were not used beyond passage 14. All
cells were maintained in a 5% CO2, 21% O2 incubator at 37 °C.
Transfections with siRNA and Plasmid DNA—Before silencing, HeLa cells were plated in antibiotic-free medium, and the
samples were silenced in serum-free culture medium with
PiC-specific (Invitrogen and OriGene; two different siRNA
duplexes) or, as a negative control, scrambled siRNAs (100 nM)
using RNAiMAX (Life Technologies). After 4-h incubation, the
medium was completed with antibiotic-free 30% FBS-containing medium. The next day, the medium was changed to normal
growth medium, and the cells were grown for 72 h. The efficacy
of the silencing was validated with Western blotting. For evaluation of mitochondrial morphology and fusion dynamics, the
cells were transfected with mtDsRed (1 g) and mtPA-GFP (1
g) plasmid DNAs using Lipofectamine 2000 (Life Technologies) 24 h before the experiment.
Growth Curves—Cell growth curves were performed in fibroblasts and HeLa cells. For all conditions, cells were counted in
duplicate wells for each time point. Cell counting was performed
using a hemocytometer. Each growth curve was performed in cells
from independent passages. For HeLa cells, growth curves were
started 72 h after treatment with siRNA; continued knockdown for
another 48 h was confirmed by Western blotting.
Mitochondrial Bioenergetics—JO2 was measured in adherent
cells using the Seahorse XF24. Fibroblasts or HeLa cells were
seeded at 40,000/well the day before the experiment. For experiments in intact cells, cells were washed two times in bicarbonate-free DMEM containing the amount of glucose in which the
cells had been cultured (i.e. 5 or 25 mM) without or with 4 mM
glutamine, pH 7.4 at 37 °C, and then 650 l of that medium/well
was added as the final assay medium. Injections of oligomycin
(0.5 g/ml final concentration), FCCP (see figure legend for
final concentrations), and antimycin (1 M final concentration)
were prepared in the respective assay media. To equilibrate
cells and degas the culture plate, cells were preincubated at
37 °C in environmental CO2 for 45 min.
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studies, cells were lysed in radioimmune precipitation assay
buffer, and then lysates were clarified and assayed for protein
content using the bicinchoninic acid assay. Immunoblotting
was carried out as described previously (33, 14). The following
antibodies were used: SLC25A3 (1:500; Sigma SAB1400208;
rabbit), complex I 37-kDa subunit (1:1000; Abcam MS111;
mouse), complex II subunit A (succinate dehydrogenase subunit A; 1:1000; Abcam MS204; mouse), complex III core 2 protein (1:1000; Abcam MS304; mouse), MFN1 (1:1000; rabbit
polyclonal provided by Richard Youle, National Institutes of
Health, Bethesda, MD), MFN2 (1:1000; mouse monoclonal
generated against MFN2(710 –757)-GST and N-terminal peptide CNSIVTVKKNKRIIM-OH provided by Heidi McBride,
McGill University, Montreal, Canada), OPA1 (1:1000; BD Biosciences 612606; mouse), Drp1 (1:500; BD Biosciences 611738;
mouse), prohibitin (1:1000; Abcam 28172; rabbit), ␣-tubulin
(1:1000; Cell Signaling Technology 2125; rabbit), cytochrome c
(1:1000; BD Pharmingen 556433), and GAPDH (1:10000;
Advanced Immunochemicals 8-GAPDH-r; rabbit). Preliminary experiments, not shown, using different amounts of
fibroblast and HeLa cell lysate were used to determine the
amount of protein that provided a signal that was within the
linear range of detection. In addition, proteins that were
used as loading controls were chosen because they did not
vary with PiC depletion.
Quantitative PCR—Total RNA was extracted from cells
using Trizol威 (Invitrogen). Purified RNA was treated with RQ1
DNase (Promega, Madison, WI) for 30 min at 37 °C. Total RNA
concentration was measured with a Qubit威 fluorometer (Invitrogen). RNA was reverse transcribed using oligo(dT)20 primers
and SuperScript III (Invitrogen). Quantitative PCRs were done
using ITaq SYBR Green Supermix with ROXTM Reference Dye
(Bio-Rad) in 20-l reactions (20 ng of cDNA/reaction) using an
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